Executive order signed protecting access to contraception and abortion nationwide
US President Joe Biden signed an executive order Friday protecting nationwide access to abortion and contraception.
Last Friday, US President Joe Biden signed an executive order protecting nationwide access to contraception and abortion.
This decision come amid the recent Supreme Court ruling on Dobbs v Jackson Women's Health Organization, which overturned previous abortion precedent Roe v Wade. That June ruling allowed for states to independently determine abortion rights.
Now, with this recent executive order, Biden will order the Health and Human Services (HHS) Department to help protect and expand medication abortion access, as well as guarantee access to contraception, family planning services, and emergency medical care.
In a press conference following the signing, Biden said, "It's outrageous. I don't care what your position is—it's outrageous and it's dangerous. That's why this executive order directs HHS to ensure all patients, including pregnant women and girls, experiencing pregnancy loss get the emergency care they need under federal law and the doctors have clear guidance on their own responsibilities and protections no matter what state they're in."
This article was initially published by our sister publication Contemporary OB/GYN.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
